Catalog Number 523292 |
Device Problem
Appropriate Term/Code Not Available (3191)
|
Patient Problems
Pain (1994); Scarring (2061)
|
Event Date 03/28/2016 |
Event Type
Injury
|
Manufacturer Narrative
|
Depuy synthes has been informed that the catalog number and lot number is not available.The asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.(b)(4).Depuy considers the investigation closed at this time.Should the product and/or additional information be received, the investigation will be re-opened.
|
|
Event Description
|
Litigation alleges patient underwent a revision to address pain and excessive levels of chromium and cobalt.
|
|
Manufacturer Narrative
|
The asr platform was voluntarily recalled from the market in august 2010, and the asr product codes are now considered inactive.Further investigation of this individual incident will not be undertaken, as there is an ongoing investigation regarding the root cause(s) and/or corrective actions.Ref.Wwcapa (b)(4).Depuy considers the investigation closed at this time.Should the product and/or additional information be received, the investigation will be re-opened.
|
|
Manufacturer Narrative
|
If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.(b)(4).Depuy still considers this case closed to capa.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Event Description
|
Update - 08/08/2016 : supplemental information received; product part/lot updated.
|
|
Manufacturer Narrative
|
Product complaint # (b)(4).Investigation summary: no device associated with this report was received for examination.The information received will be retained for potential series investigations if triggered by trend analysis, post market surveillance, or other events within the quality system.Depuy considers the investigation closed.Should additional information be received, the information will be reviewed and the investigation will be re-opened as necessary.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
|
Manufacturer Narrative
|
Depuy synthese is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthese has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthese or its employees that the report constitutes an admission that the device, depuy synthese, or its employees caused or contributed to the potential event described in this report.
|
|
Event Description
|
Update ad (b)(6) 2018: (b)(4) has been re-opened under (b)(4) due to receipt of medical records.After review of medical records for mdr reportability it was reported that the patient was revised to address worsening increased of metal ion levels.Revision note stated, there was scarring in the posterior structures from her prior surgery.The joint fluid was clear without evidence of purulence, no evidence of metallosis.There were no laboratory values provided for the elevated metal ion levels.Doi: (b)(6) 2008 : dor: (b)(6) 2016 (right hip).
|
|
Search Alerts/Recalls
|